Patients and caregivers are often interested in learning more about clinical trials for brain tumors. It can be confusing and overwhelming to understand what clinical trial may be best for you or your loved one. The NBTS Clinical Trial Finder is an easy way to search for a local trial treatment for your specific tumor type.
Finding a Trial
Use these filters to find a trial that meets your needs. If you are interested in learning more about a trial, contact the site coordinator via email or phone. We strongly recommend that you consult with your healthcare provider about the trials that interest you and refer to our terms of service below.
NBTS Patient Navigator
National Brain Tumor Society’s patient navigator is available to you to answer questions as you review your search results from the NBTS Clinical Trial Finder and can also assist you in identifying questions for you to pose with your healthcare provider. You can reach our patient navigator at firstname.lastname@example.org.
About Clinical Trials
The purpose of a clinical trial is to determine the most effective and safest treatment for a disease. Clinical trial evaluation is a key step to translating research into new medicines that can provide better outcomes for patients. The performance of clinical trials is a vital component of the U.S. Food and Drug Administration’s drug approval process, without which advances in therapeutics for brain tumor patients would not be possible. Often the lengthiest aspect of the drug approval process is finding people to participate in trials. The NBTS Clinical Trial Finder is intended to help raise awareness and increase participation in clinical trials to facilitate brain tumor research and accelerate the development of new drugs and treatments for patients.
The trials included in the NBTS Clinical Trial Finder are listed on ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.